Новости GxP

gxpnews.net

#25 in Health among publishers in Google Discover in Kazakhstan over the last 30 days.

Track in D2TR
KazakhstanLast 30 days
#25in Health
39DTRSDTRS, its score in Health
0.01%share of visibility
#25in Health

Reach per publication

76market average is 100A typical ⁨Новости GxP⁩ publication reaches less of Discover than the average one in this market.

Publication lifespan

1.1×the market averageIts publications stay in the feed longer than most before they drop out.
Feed positionAverage position in the feed and the number of publications are in D2TR.

Market share

Last 60 days
Share of visibilityImpressions per day5.4Kin the last 14 days
0.0%0.1%0.2%0.3%0.4%0.5%01K2K3K4K5KLast 14 daysSep 17Oct 2Oct 18Nov 2Nov 150.0%0.5%1.0%02.5K5KLast 14 daysSep 17Nov 2Impressions before Nov 2 are in D2TRUnlock the full historySign up to see daily impressions of ⁦gxpnews.net⁩ since September 2026 and every article behind them.Sign up

Slice of the market

0.01%of all Google Discover visibility in Kazakhstan
  • Новости GxP0.01%
  • Rest of the top 1040.2%
  • Everyone else59.8%

Top publications

В России разработали новый препарат от тромбов

New anti-clot drug developed in Russia

Impressions5.2K
HealthIn D2TR

Татьяна Голикова: онковакцину CaTeVac планируют применять с 2027 года

Tatiana Golikova: CaTeVac cancer vaccine planned for use from 2027

Impressions102
HealthIn D2TR

FDA взялось за расследование информации о риске развития опухолей после введения «Золгенсмы»

FDA launches investigation into reports of tumor risk after Zolgensma administration

Impressions36
HealthIn D2TR

Пациенты указали на отсутствие в аптеках импортного препарата для лечения атопического дерматита

Patients report absence of imported drug Elidel for atopic dermatitis treatment in pharmacies

Impressions
HealthIn D2TR

Publications by impressions

ImpressionsPubsShare of total
Over 5M0%0%
1M to 5M0%0%
100K to 1M0%0%
10K to 100K0%0%
Under 10K100%100%

100% of its publications bring 100% of its impressions.

Where it ranks

By category

Impressions, last 14 days
Health5.4KUp 24 places against the previous period#25
Other categories0

What it publishes

Content formats

  • News100.0%

Top authors

Last 14 days
GxP News5.3K

Who it competes with

Top competitors

Shared trends
Наука Mailscience.mail.ru1 trend

Trends they share

Times they met
Russian anti-clot drug Angipur advances in clinical trialsagainst ⁨Наука Mail⁩1 time
Every trend it competes on, in D2TR

About ⁨Новости GxP⁩

Main category
Health
In D2TR data
since September 2026

Google profile

Open profile
0total followers
Last 90 days

Its records

Best rank
outside the top 50 October
In the top 10
in no period on record
The numbers behind the rankSign up to open the full impressions history, feed positions, authors and every article of ⁦gxpnews.net⁩.
Sign up

Rank and share come from the D2TR publisher ranking and are rebuilt every 7 days. Impressions are shown for the last 14 days. Estimates, not Google data. D2TR is not affiliated with Google or with ⁨Новости GxP⁩.